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Abstract:
Cancer is the

second leading cause of death despite the anti cancer developments

including hormone therapy, radiotherapy, chemotherapy. Chemotherapy includes use of
potent drugs such as camptothecin, paclitaxel and mitomycin. These drugs have a effect
which is dose responsive, where the drug exposure and cell kill are proportional. This
chemotherapy is high dose and has less selectivity for cancer cells and has more toxic
effect to normal cells. Such kind of non specific treatment to tumor is causing hurdles in
the treatment of cancer by chemotherapy. To overcome this current limitation to
chemotherapy, the anti cancer drug with high specificity is given in concentration
effective to the tumor tissues. [1, 2][1, 2][1, 2] In order to achieve this goal, tumor
selective

drugs

were developed

by

conjugating

antibodies,

hormones

and

vitamin

derivatives to anti cancer drugs. One such compound, folic acid, which is low molecular
weight vitamin, has emerged as ligand for delivery of drugs to cancer tissues. Since the
folate receptors are over expressed in cancer cells, conjugation of anticancer drugs with folate
serves as a highly effective way to treat cancer with fewer side effects. This way, the normal
cells can be prevented from the toxic effects of the anticancer drugs. Hence, folate receptors can
be used as a useful tool for selective targeting of drugs. [3]
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Introduction:
Folic Acid:

Folate

plays

an

important role as it participates in the biosynthesis of nucleic and

amino acids and thus is essential in cell survival. [4] It is a member of vitamin B family.
Folate is used to enhance the differential specificity of anticancer drugs as it targets the
folate receptor positive cancer cells. By this property it serves as a high affinity ligand.
Conjugation of anticancer drugs to folate was found to decrease the side effects and
increase the drug selectivity . FR is a

glycosylphosphatidylinositol anchored protein,

which is associated with tumor. It can internalize the folates which are bound and
conjugated compounds bound to folate via receptor mediated endocytosis. The FR density
is found to be high in breast carcinomas and low levels are found in normal tissues. Its
density was also found to increase as the cancer progresses. A wide range of anti cancer
drugs were conjugated and evaluated for their anti cancer activity based on the fact that
conjugation of folate helps in targeting the drug molecule and getting endocytosed into
cells with positive FR. Such drugs include EC 72 , EC 118 and folate mitomycin. These
were found to have selectivity for FR positive M109 cells. When these E118 and EC 72
were studied in vivo and in vitro, it was proved that drug specificity and selectivity was
enhanced by folate conjugation more over reducing the toxicity. [1]
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Folate Receptors:

The folate receptor was found to have two isoforms which are glycosyl phoshatidylinositol
(GPI) anchored. They are alpha and beta. Epithelial cancers are usually associated with FRalpha expression and myeloid leukemia and activated macrophages are associated with
FR- beta expression. The targeted delivery to FR+ cells is done via receptor mediated
endocytosis, the anti FR antibodies and conjugates of folic acid can be up taken by
cancer cells. So the FR alpha is used as a marker in cancer and beta for inflammatory
diseases and myeloid leukemia. Thus FR targeting agents find a good potential for
treatment of range of diseases.[5]
When the stability and structure of folate binding protein FBP from cow's whey was
studied, it was found that it has 22 % helix, 5 % parallel beta strand, 17 % turn 25 %
ant parallel beta strand and 31 % random coil structure. Spectroscopy studies showed that
when folate binding occurs to folate binding protein, significant changes occurs and there
was a 10 % decrease in the anti parallel beta strand. The magnitude of ligand binding
was found to be proportional to quenching of FBP tryptophan fluorescence. Further
studies revealed that because of the ligand binding to FBP, the folding stability of the
molecule was increased which is by the aggregation of FBP caused by ligand. This was
also confirmed by fluorescence and

spectroscopy.
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Current clinical trials show that conjugation with folate increases the potency and reduces
the toxicity of many anti

cancer drugs. Drugs that are conjugated to folic acid for

selective drug delivery are : Chemotherapeutic agents, Protein toxins, Gene therapy
Vectors, Radio imaging agents, Radiotherapeutic agents, Liposomes with entrapped drugs,
immunotherapeutic agents, oligonucleotides ( SiRNA ), MRI contrast agents.[6]

Folate receptors were discovered to be over expressed on activated macrophages and
found to be quiescent on non activated macrophages. The cause and contribution of
activated macrophages to a number of diseases as diabetes, rheumatoid arthritis, ischemia,
sarcoidosis, psoriasis, vasculities, sjogrens disease, led to studies which were done to
develop folate conjugated therapeutic agents. To visually examine the delivery of folate
conjugates into receptor bearing cells, Susan Wang and Phillip Low used bovine igG and
bovine ribonuclease. This was conjugated to folic acid and 15 nm colloidal gold particles
where used to label them.

[7] Florescent probes were used to label them and then

conjugated to folic acid. By florescent microscopy it was revealed that only the
florescent proteins which are folate conjugated were taken by the folate receptor KB
cells.[1]

After the folate protein conjugates are up taken by cancer cells, EM pictures of KB cells
revealed the internalization of colloidal gold particles by KB cells through uncoated pits.
Mostly the ligands delivered by endocytic pathways into cells are internalized for
destruction. That means, the hormones after they transduce their signals or any other
foreign particle which are harmful if they remain in the cell are digested by the
lysosomes. But the folate conjugates were found to be stable and functional after many
8

hours of uptake by cancer cells. So the folic acid is internalized for consumption and
not for destruction. Thus it was found that after uptake by the FBP, the nucleic acids
and proteins remain undigested and enzymes retain their activities. [8]

Upregulation of folate receptors:

Until late 1991 and early 1992 the knowledge of FR up regulation on cancer cells was
not obtained until it was studied that the FR was actually recognized by the monoclonal
antibodies used in tissue biopsies to study cancer cells. Mainly, two different classes of
proteins mediate the cellular uptake and absorption of folate [9]. One is the reduced folate carrier
(RFC) are the transmembrane proteins, which have micro molar affinity to bind with the reduced
folate. The second class is the folate binding proteins family also called as folate receptor.
Further learning on the distribution of FR actually gave a new approach to the cancer
research that the FR is mainly restricted to malignant tissues rather than normal tissues.
From then, FR was used as a tool for selective targeting of drugs to the cancer cells.
This study lead to the development of folate linked cytotoxic drugs. When the linkage of
folate pseudomonas exotoxin ( PE38) and folic acid was studied, it was demonstrated
that the effect of the conjugate was depending on the type of the bond between them.
With the reducible disulphide bond linkage, maximum potency was observed and with
thioether bond, there was a decrease in its potency. Thus with these demonstrations it
was shown that the cleavable linker in the folate targeted cytotoxic drug was important
in the designs of future conjugated drug designs. [10, 11]

9

Imaging of Folate Receptor Tumors:
Imaging of folate receptor tumors was found to be feasible using radio labeled folate
conjugates.

The

chelating

agents

that

have

high

affinity

for

γ-emitting

metal

radionuclide’s are used after folate derivatization. Folate was conjugated with chelator
deferroxamine and labeled with 67Ga, this was intravenously injected into mice with
xerographic implants from cells cultured with KB. Thus high tumor selectivity was
achieved by folate targeted imaging agents. Studies show that it helps in detecting the
size, location and clinical stage of neoplastic tissue and thus used in planning the
treatment strategy for cancer. Recent studies showed that folate targeted liposomes are
being effectively used for gene therapy. [11] The gene therapy agents commonly used are
expression plasmids and antisense oligonucleotides. Their uses are limited because of
their low physiological stability, and lack of tissue specificity. Because of these
disadvantages , these macromolecules are being taken into consideration to enhance their
stability and permeability. To protect the antisense oligonucleotides from nuclease
digestion, folate targeted liposomes are used which also enhances their intracellular
delivery. Treatment of KB cells with free antisense oligos and antisense oligos
encapsulated in folate liposomes showed that free oligos had barely growth inhibition and
no significant changes. But with the use of folate PEG liposomes , there was measurable
growth inhibition and abnormalities in the morphology. Further studies proved that
encapsulated oligos showed complete suppression of growth factor receptor thus indicating
the efficiency and non destructive delivery of encapsulated oligos into cancer cells. [12]
Because of the inefficient escape of plasmids from the cell's endosomal compartments ,
the use folate targeted carriers

has been limited in the tumor specific delivery of
10

vectors. To overcome this issue, studies were conducted to modify the liposomes such
that they deliver their effects only after entering the target cell endosomes. One approach
which was used by developing a ph sensitive lipid composition . This becomes lysogenic
after entering into acidic endosomes. [13] The other approach uses the fusogenic oligopeptide.
This initiates membrane fusion by changing the conformation. By testing cytosine arabinoside,
an anticancer drug in folate liposomal preparation, the effectiveness was found to
increase by folate targeting. The potency was found to increase further by constructing
ph sensitive diplasmalogen. Thus the use of pH sensitive lipid design and peptide will
have great impact on efficiency of expression. Furthermore, the use of conjugated
nanoparticles with folic acid proved to have targeted effect in treatment of cancer. This
effect was shown by particles which have biodegradable polymer core and mixed lipid
monolayer shell. Docetaxel when used with the nanoparticles showed a markable increase
in

the

cytotoxic

effect. Furthermore

another

advantage

of

using

the

drug

with

nanoparticles is that the targeting effect can be controlled and adjusted by lipid
component ratio of mixed lipid monolayer. This targeting efficiency of lipid monolayer
was proved by fluorescent microscopy which shows that controlled and targeted delivery
is achieved by folic acid conjugated nanoparticles which can be the drug delivery system
where the targeting effect is precisely controlled.[14]

Folate Conjugates:
Another type of folate nanoconjugates were synthesized which were found to be magneto
fluorescent and cancer specific targeting folate conjugates [15] . These particles were
11

designed with pendant groups ( amino, carboxyl ) on their surface with o carboxymethyl chitosan ( OCMC). These groups facilitate in

covalent attachment of

rhodamine isothiocyanate ( RITC) which is a fluorescent dye. the magneto fluorescent
nanoparticles were conjugated on to the aminated derivative of folic acid. These magneto
fluorescent conjugates were found to be biocompatible, with good dispersibility . In the
presence of external magnetic field they were found to have specific magnetic properties.
Further studies were done using folate over expressed ( HeLa) and normal cells. It was
proved that the uptake of these nanoparticles folate conjugates is more in cancer cells
than in normal cells.[10]

CdHgTe folate conjugates :

These

were found to have stability , optical spectra and

cancer cell targeting characteristics. They were prepared by covalent conjugation of folic
acid and CDHgTe quantum dots. The fluorescent wavelength of CdHgTe folate
conjugates was found to be 790 nm . The long and continuous fluorescence imaging was
achieved by these conjugates because of their fluorescence stability. The bio distributions
of these conjugates were studied in vivo in S180 tumor mouse which proved their tumor
targeting efficiency. These CdHgTe folate conjugates can be used for monitoring and
imaging because of their high fluorescence intensity. The intracellular delivery against
folate

receptor

is

enhanced

by

heparin-PEG-folate

(H-PEG-F). In this, the folate is

conjugated with succinylated heparin. Since it is has amphiphilic property as it has
covalent bonding, it can be used with hydrophobic drug such as taxol. Nanoparticles
made with the drug and H-PEG-F have the drug in the core with folate on its surface.
[16] By UV technique, the quantitative analysis of folate and taxol is studied and NMR
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technique, the particles are characterized for their structure. Size of the nanoparticles is
studied by field emission scanning electron microscopy ( FESEM ) . When these
nanoparticles were studied for their effect, it was shown that the cellular uptake of the
carrier by KB-3-1 cells which are the folate receptor over expressing cell line is more
than for the folate receptor deficiency cell line.

With the help of flow cytometry, it

was depicted that when the KB-3-1 cells were treated with nanoparticles , the G2/M
phase of cell cycle was found to be arrested. This effect it similar to the inhibition
mechanism of taxol. With the help of these folate conjugated nanoparticles various
therapeutic agents can be used for cancer cell targeted delivery.

The conjugation of

folic acid to chitosan molecules was done via the gamma carboxyl moiety. This helps in
retaining a high affinity for folate receptor over expression in colorectal cancer cells. For
the detection of colorectal cancer , folic acid conjugated with chitosan nanoparticles is
used for carrying 5- amino aevulinic acid (5-ALA). Folic acid -chitosan conjugates were
prepared and then 5-ALA was loaded to form fCNA nanoparticles. When these
nanoparticles were used to study their uptake, it was found that the fCNA particles were
taken up more easily by caco-2 cell lines and HT29 cells. Since the colorectal cancer is
often undetected with current colonoscopy practices it is the major leading cause of
malignant death. With the use of these folic acid -chitosan conjugates the colorectal
specific delivery of 5- ALA appears to be an ideal option in the endoscopic detection of
colorectal cancer. [17]

Folate receptor beta expressed by tumor-associated macrophages:
According

to

their

response

to

pro-th1/proinflammatory

stimuli

or

pro-Th2/anti-

inflammatory stimuli ,activated macrophages are grouped functionally. The folate receptor
13

beta (FR beta) which is encoded by FOLR2 is expressed with increased folate uptake
ability. M-CSF promotes the folate uptake ability of macrophages and thus indicates a
link between M2 polarization and FR beta expression. The tumor associated macrophages
(TAM) exhibits M2 like functional profile and helps in detecting the FR beta expression.
[5] The expression of FR beta mediates folate uptake by CD68(+) CD14(+) CD163(+).
The ascetic fluid of the tumor and the medium of tumor cell induces the expression in
an M-CSF dependent manner. The high degree of macrophage infiltration is usually
associated with tumor associated macrophages ( TAMs) found in glioblastomas. In an
experiment conducted to study the expression of folate receptors, a rat C6 glioma
subcutaneously implanted in nude mice, recombinant immunotoxin was produced to target
TAMs with FR beta expression. It consisted of immunoglobulin heavy and light chain
portions and pseudomonas exotoxin A. C6 glioma xenografts when injected with the
immunotoxin was shown to deplete TAMs and thus inhibiting the growth of the tumor.
FR beta expressing macrophages targeted by the immunotoxin provides a good
therapeutic tool in the treatment of glioblastomas. These studies indicate that FR beta is
a marker in M2 regulatory macrophage polarization.[4]
Folate Quantum Dots:

The folate quantum dots were synthesized with folate poly ethylene glycol conjugates
and polyamidoamine (PAMAM ) . [18] These are useful in the design and development
for bio imaging and optical imaging of cancer cells. The CdSe/ZnS dots were found to
encapsulate the ligand by ligand exchange reactions. These ligand exchanged QDs were
found to target the tumor cells because of membrane expression of folate receptors. The
cellular uptake of FPP coated QDs is more in HeLa cells when compared to QDs
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without folate. The FPP quantum dots show slow endosomal escape after binding to the
tumor cell surface. After entering , they release into the tumor cells.[19]
The anticancer drug Irinotecan is used in the treatment of colon cancer but its active
metabolite , SN-38 (7-ethyl-10-hydroxycamptothecin) which is very hydrophobic was
found to be more cytotoxic than the original drug. To improve the stability and
solubility SN 38 was formulated into folate nanoparticles. These were produced by
emulsification of poly lactide co glycolide polyethylene glycol with SN -38 . By
coupling of PLGA-PEG-NH diblock copolymer with folic acid, the folate- conjugated di
block copolymer were synthesized. When these conjugates were studied against HT-29
cancer cells, it was shown that the S38 loaded particles have strong cytotoxic effects
than with the control . [20] With this study it was demonstrated that for the hydrophilic
drugs, folate conjugation is the efficient way for to increase the cytotoxicity of the drug.
Folic acid conjugation was done to bovine serum albumin nanoparticles (BSANP). Into
the folate conjugated albumin nanoparticles, mitoxantrone was incorporated. These
nanoparticles were used to target SKOv3 cells where the folate receptors are over
expressed. Incorporation of mitoxantrone to the nanoparticles lead to the cytotoxic
activity of MTO-BSANP-folate. This activity was quantitatively determined and was
found to be more when compared to just the MTO-BSANP and MTO solution in vivo.
Thus it was shown that folate conjugated BSANP have good potential in the cancer
chemotherapy. [9]
Glutathione modified Gold Nanoparticles:
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Because of the over expression of folate receptors on variety of cancers, the therapeutic
agents and folate linked imaging can be targeted to FR expressing tumors. In this way,
uptake by the healthy tissues can be avoided which express very less FR. Using gold
nano particles, the drug glutathione was modified to form GSH- capped GNPs. These
particles have carboxyl group on their surface [20] .Though the reaction of amino group on
folic acid, these particles were conjugated .In aqueous solution the folic acid conjugated
gold nanoparticles were found to be stable. By transmission electron microscopy it was
confirmed that the FA-GSH-GNPs were up taken by the human cervices carcinoma cells
which showed high level of folate receptor expression. In cells which lack folate
receptor, no uptake was seen . The relative absorbance of the supernatant was measured
with HeLa cells incubated with FA-GSH-GNPs. The HeLa cells were detection with the
detection limit of 10(2) cells /mL by spectroscopic method.

As in the case of

methotrexate, which is used in the treatment of rheumatoid arthritis, the targeting
mechanism plays an important role in the treatment. MTX because of it plasma protein
binding is responsible for its effective distribution in the body. in RA patients, the
expression of folate receptor β (FR-β) is found to be high on synovial macrophages. This
mediates in high uptake of MTX in the cells. Such studies conclude the FR-β specific
therapy and is being employed for drugs other than MTX.[6]

Detection of folate binding protein by optical biosensor analysis:
Biosensor is based on SPR technique. It is the surface plasma resonance technique. In SPR
system, there is a laser light source which produces light, detector, gold surface and a glass
16

prism. The incident polarized light under goes total internal reflection and this is configured at
the interface. The electromagnetic field which is generated gets penetrated into the metal and
then it transfers some of its energy to its valence electrons. This produces charge density waves
which are known as Surface plasmons[5]. When there is any association or dissociation at the
sensor surface, it is recorded as a plot of change in refractive index with time.[21]

Detection of folate binding protein in milk:
In early 1960's Ghitis observed that there is a presence of a macro molecular factor in milk which
is heat labile. This factor prevented the adsorption of milk folate onto the activated charcoal.
Furthermore observations lead to the conclusion that the high affinity folate binding protein is
present in bovine milk which prevents the milk from adsorption on to charcoal. This FBP was
found to contain 222 amino acids.[22, 23]
The interactions of folate and FBP are essential for study of metabolism of folate and the
bioavailability of folate. In the indirect technique for FBP quantification, the folate content was
measured after the unbound folate which is excessive is absorbed onto charcoal. The direct
technique for determination of FBP was ELISA. [24] This is done by a antibody which is raised
against the FBP in milk. These two techniques do not determine the complexation of FBP with
folate. To distinguish the free apo form from the complexed holo form, a technique was
discovered which was called the Surface Plasma resonance (SPR). The SPR technique works by
measuring the refractive index near the surface. By this method, the apo form of the protein can
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be easily measured. The most commonly used SPR system is the Biacore system by GE health
care Sweden.[23]

Analysis with Biacore system:
The components of Biacore system are: interchangeable sensor chip, micro fluidic sample
handling system and SPR detector. The sensor chip consists of a glass slide which is plated with
gold. A coupling matrix is used which covers the gold film .This coupling matrix is important
because it reduces the mobilization capacity of the molecules and hence for characteristics of the
surface. The non specific absorption of proteins is prevented because of the hydrophilic property
of the matrix. The interacting partners are immobilized on to the sensor chip surface and the
aqueous samples are injected onto this surface. To control the flow of buffer over the sensor
surface, IFC i.e., integrated micro -fluidic cartridge is used which gives a continuous flow [25]
.The detector detects the binding of interactant and is quantified in real time. The interaction is
detected when analyte which is the binding partner binds to the immobilized molecule on the
sensor surface. The coupling of activated dextran to the amine group was not possible because
for the binding to occur, a ring system is important. So the sample folic acid which was used
were coupled on the sensor surface to the amino groups were in their hydroxysuccinimidyl
forms. Because of the amine coupling, the FBP is immobilized on the sensor surface. When this
binding takes place, there is an increase in the mass at the surface and this result in change in
refractive index. This change is measured real time and a graph is plotted with resonance units or
response with time. This plot with Resonance Units and time is called a Sensogram. The
sensogram gives information about the interaction rate (association or dissociation) through
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which the concentration of analyte can be known, the affinity constants are obtained from the
binding level information.[25]

Concentration Analysis:
In this assay, only the binding which is specific to the two samples is studied. To determine the
amount of analyte bound, the rate at which the analyte binding occurs at the beginning when the
sample is injected can be taken into account .The other approach is to measure the total amount
of analyte which has binded after the whole sample injection. The rate of binding is directly
proportional to the concentration of analyte when the association of the samples is dependent on
the rate at which the samples are transported. [26]
This method was shown to be in compliance with ELISA method. It was also found that at FBP
concentration of 0.38µg/mL, the repeatability (CV) was found to be 1.2 - 3.6 % within assay for
3 different days. This method is based on interaction of the PGA and FBP, so the folate which is
endogenous must be removed to estimate the total FBP content because it can interfere with the
assay method. For this assay to be done, the presence of pteridine moiety of folate was important
for the interaction to occur. [26]
From the data obtained by the interaction of the analyte and the ligand at the sensor surface, the
association, dissociation and the equilibrium constants can be analyzed. By this SPR technique,
the free and the apo form of FBP can be differentiated so that the effect of FBP on the stability of
folate can be known. For the study of the specific interactions of protein- vitamin, this modern
technique is highly useful.[8, 27]
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Detection of folate binding protein with Megalin:
Megalin is a member of low density lipoprotein receptor family. It is a multiligand endocytic
receptor which is mainly expressed in proximal tubule of kidney, intestine and other absorptive
epithelia.[27] This megalin has an affinity to bind to the FBP present in milk. In early 2000, the
research conducted on uptake of FBP by megalin showed that megalin has high affinity to bind
to the FBP but it cannot bind to the low density lipoprotein receptor protein. When this study was
done on immortalized rat yolk sac cells, it showed that the 125I- labeled FBP was up taken by
the megalin and this uptake was inhibited by antimegalin antibodies and also by the receptor
associated proteins. When 125-I labeled FBP was injected into proximal tubule in vivo, there
was endocytotic uptake in the renal tubules. Since the human body cannot synthesize folate, the
up regulation of folate is very important in the intestines.[14]

Binding of FBP and Megalin:
The binding of bovine milk apo FBP to immobilized rabbit megalin was shown by SPR
techniques. This binding was also observed with 5-methyltetrahydrofolate (5-MTHF), or
methotrexate. Autoradiography techniques were used to confirm the binding of FBP to megalin
in proximal tubule brush border membranes of kidney. On incubation with 125I labeled bovine
milk FBP, autoradiographic grains were shown to be accumulated along the proximal tubule
which was inhibited by incubation with receptor associated protein. [8]This receptor associated
protein is a known inhibitor of megalin. It inhibits the ligands uptake by megalin, thus it shows
that megalin has a very specific binding capacity [8] .The uptake of FBP by megalin was
calculated as the sum of cell associated, degraded and non trichloroacetic acid precipitable label.
20

Detection of folate binding protein by Quartz Crystal Microbalance Sensor:
Because of the fact that FBP are present in both the normal and metastatic states, radio
immunoassays are employed for their detection. These involve the use of radioactive labels
which are hazardous and also the analysis time is long for the detection. To overcome this, a
quartz crystal microbalance method (QCM) was discovered in 2006 which allows the recognition
of antigen antibody, assess the surface layer phenomenon and also the capture of viral and
bacterial cell. For the detection of folate binding protein, a quartz crystal microbalance
biosensor was developed.[5] Detection limit of 30 nm was achieved with Au coated
quartz sensor absorbed with simple folate BSA conjugate. At concentrations higher than
1 micro molar in excess of folic acid, the binding of FBP to sensor surface are blocked.
This showed the specificity of folate FBP interaction. When there is an association or
dissociation of protein to the surface of the quartz sensor, change in the mass of the crystal
occurs. This results in the increase or decrease in the frequency. When the analyte gets captured
on the crystal surface, the effective surfaces mass increases, and thus the resonance frequency
decreases. This decrease in the frequency is because of the binding of the proteins to the quartz
surface. Since the molecular weight of the analyte protein could be very small, some secondary
ligands such as iron or gold particles are employed. These ligands increase the sensitivity by
increase in the mass of the analyte binding to the surface. Thus with the use of quartz crystal
microbalance analysis, the sensitivity of the assay was increased significantly.[7, 28]
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The basic operation of QSM described by Sauerbrey is given as
(∆mQCM

) = - (CQCM/n) ∆f where CQCM (17.7 ng cm-2 Hz-1) is the mass sensitivity

constant and n (1, 3 ...) is the overtone number, ∆ m is the mass change, and ∆f is the change in
resonance frequency. [5]

Imaging Studies:
In early 2005 ,further studies were in the field of

the in vivo imaging of arthritis which

is the inflammatory joint disease was done using a lipopolysacharide intra articular
injection model and a KRN transgenic mice serum induction mouse model for the testing
of a recently developed near infra red fluorescence labeled folate probe ( NIR2 -folate)
[29] .Arthritis is characterized by active macrophages with over expressed FR receptors.
In the joints with lipopolysaccharide treated and the control joints, the fluorescence signal
intensity of free and NIR2 folate was compared.

At the NIR2 folate probe, the

fluorescence signal intensity was found to be higher than control normal joints .After the
transfer of serum, the NIR2 folate was applied at different time points in the KRN
serum transfer model. After the transfer of arthritogenic antibody transfer, the inflamed
joints were detected after 30 hours and shown to have an increase of 1.8 fold in the
intensity of the signal. Thus it was concluded in this study that using a fluorescent
probe, the in vivo detection of arthritis could be done and hence with this receptor
targeting method, improved arthritis diagnosis can be facilitated.[30]
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Conclusion:
As there is a vast potential for folate targeting anti cancer drugs, the study and detection of folate
binding protein provides an essential tool for diagnosis and monitoring the therapy for treatment
of cancer. These folate delivery systems are essential to establish the level of folate receptors
required for the cancer cells to be treated by the folate targeting drugs. By various SPR
techniques, a simple fast and robust method was developed to distinguish the apo and the holo
forms of FBP. The future studies in this field are the use of nanomechanical sensors which can
further explore the detection capacity of biosensors for eg, in relation to the work done by Dr
Henne by using Quartz crystal microbalance sensor, the use of nanomechanical sensors gives a
new approach to the folate targeting of the drugs. Applications and development of various other
cantilever based sensors is presently being studied by the International Workshop on
Nanomechanical Sensors.

FIGURES:

Anne Marie Helmenstine, Ph.D.

Figure 1: Structure of folic acid [4]
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Figure 2: Folate receptor mediated endocytosis [3]
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Figure 3: Folic acid Expression [14]
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Figure 4: Surface plasmon resonance (SPR) biosensor principle. [31]
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Figure 5: Overview of the basic interactions at the biosensor surface. [31]
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Figure 6: Sensorgram.[31]
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W. Henne, Analytical Chem 2006.
Figure 7: Sensor surface functionalization for the detection of folate binding protein. [5]
(a)Folate BSA is adsorbed on the QCM gold sensor surface and used as a receptor to
capture FBP. (b) Signal enhancement is obtained by addition of anti-FBP antibody,
followed by subsequent protein-A-coated gold nanospheres. (c) Structure of folic
acid.[20]
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W. Henne, Analytical Chem 2006
Figure 8 : Quartz Crystal Microbalance Sensor

Nature Reviews Molecular Cell Biology 3, 258-268 (April 2002)
Figure 9: Structure of Megalin featuring regions containing pathogenic epitopes in Heymann
Nephritis.[1]
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H.Birn,Jan Holm. FEBS Journal 272 (2005)
Figure 10: Autoradiography showing RAP-inhibitable binding of soluble 125I-labeled FBP to
proximal tubules of rat kidney cortex [1]

30

H.Birn,Jan Holm. FEBS Journal 272 (2005)

Figure 11: Uptake of 125I-labeled bovine milk FBP microinjected into rat nephrons in vivo.
Uptake of 125I-labeled FBP is visualized by autoradiography on sections from fixed kidney
cortex. Grains are located over proximal tubule profiles.[1]

Arthritis Res Ther. 2005;7(2): R310-7. Epub 2005 Jan 14.

Figure 12: Early detection of the inflammatory joint by NIR2-folate.
(a) White-light image showed no remarkable swelling at bilateral paws. (b) Merged nearinfrared fluorescent signal with a white-light image showed increase fluorescence signal
intensity at the dorsal aspect of the right wrist, which has a 1.8-fold increase compared
31

with the left wrist. (c) H&E-stain histology of the right wrist showed polymorphonuclear
cell infiltration at the dorsal aspect of the right wrist (arrow).
(d) Histology of the left wrist showed no remarkable inflammatory cell infiltration. (e)
Immunohistochemistry of the right wrist showed Mac-3-positive cell infiltration at sub
synovial tissues. [32, 33]

Arthritis Res Ther. 2005;7(2): R310-7. Epub 2005 Jan 14.

Figure 13: Establishment of the KRN serum transfer model. [7]
(a) Discoloration and swelling (arrow) of the right third proximal interphalangeal joint is noted in
a healthy C57BL/6 mouse 4 days after KRN serum transfer. (b) Near-infrared fluorescent
imaging of the right paw showed increase fluorescence signal intensity at the inflammatory joint
(enhancement ratio = 1.9). (c) Correlated H&E-stain section showed abundant inflammatory
cells infiltration with pannus-like formation. (d) Immunoperoxidase staining of Mac-3. Mac-3positive cell infiltration among polymorphonuclear cells was noted in the pannus.[34]
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Figure 14 :In vivo near-infrared fluorescent (NIRF) imaging of inflammatory joints in the
lipopolysaccharide (LPS) induction model [35]
The NIR2-folate probe was intravenously injected 2 days after LPS intra-articular injection. (a)
White-light images obtained 48 hours after intra-articular LPS injection at the right ankle joint;
soft tissue swelling was noted at the affected joint. (b) NIRF images obtained 24 hours after
NIR2-folate injection. (c) A merged NIRF signal with a white-light image showing specific
increased fluorescence signal intensity at the affected joint. (d) H&E-stain section of the right
ankle joint showing abundant inflammatory cell infiltration at sub synovial tissues. (e) NIRF
images of a longitudinal section of the LPS-treated ankles.[34]

Arthritis Res Ther. 2005;7(2): R310-7. Epub 2005 Jan 14.

Figure 15: Immunoperoxidase staining
(a) Mac-3 and (b) folate receptor (FR) at an arthritic ankle 72 hours after lipopolysaccharide
induction. The Mac-3-positive and FR-positive cells morphologically correlated well in adjacent
tissue sections. [7]
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